CYP46A1 and cervical cancer: Recurrent deletion peaks/genes previously unreported in cervical cancer include 2q37.1 (MIR562, DIS3L2, 41%), 4q22.1 (CCSER1, 43%), 5q12.1 (PDE4D, 24%), 6p25.3 (FOXQ1, 16%), 6p26 (PACRG, PARK2), 8p23.2 (CSMD1, 9%), 11q14.2 (PICALM, EED, 38%), 11q23.3 (PVRL1, 54%), 11q25 (NTM, 53%), 14q32.2 (CYP46A1, 16%), 15q15.1 (MIR4310, 21%), 16q11.2 (ZNF267, TP53TG3 family, 17%), and Xp11.3 (KDM6A, 22%) (Supplementary Table 7b).